Sujan v. Corona Regional Medical Center CA4/2

California Court of Appeal·Decided March 8, 2021·No. E071217·Unpublished

Opinion

Filed 3/8/21 Sujan v. Corona Regional Medical Center CA4/2

NOT TO BE PUBLISHED IN OFFICIAL REPORTS California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA FOURTH APPELLATE DISTRICT DIVISION TWO

SUNIL SUJAN et al., Plaintiffs and Respondents, E071217 v. (Super.Ct.No. RIC1717505)

CORONA REGIONAL MEDICAL OPINION CENTER INC., et al.,

Defendants and Appellants.

APPEAL from the Superior Court of Riverside County. Irma Poole Asberry, Judge. Affirmed.

Lewis Brisbois Bisgaard & Smith, Raul L. Martinez; Nossaman, Carol Coppo and David M. Balfour for Defendants and Appellants.

Milstein Jackson Fairchild & Wade, Lee Jackson, Gillian L. Wade, Mayo L.

Makarczyk; Kabateck Brown Kellner, Brian S. Kabateck, Anastasia K. Mazzella and Christopher B. Noyes for Plaintiffs and Respondents.

Plaintiff Sunil Sujan, a physician who formerly practiced medicine with defendant Corona Regional Medical Center (CRMC), filed this lawsuit alleging CRMC and three individual defendants (Alaa Afifi, M.D., Imdad N. Yusufaly, M.D., and Ahmed El- Bershawi, M.D.) engaged in a concerted scheme to defame him and ruin his professional reputation, and summarily suspended his admitting privileges. Defendants appeal the trial court’s denial of their Anti-SLAPP1 motions. The trial court concluded, and we agree, that: (1) four of Sujan’s causes of action challenge his suspension and therefore do not arise from a protected activity; and (2) although Sujan’s causes of action for defamation and intentional infliction of emotional distress (IIED) do arise from protected peer review activity, there is a probability Sujan will succeed on the merits of those claims. Therefore, we affirm.2

1“SLAPP is an acronym for ‘strategic lawsuit against public participation.’”

(Jarrow Formulas, Inc. v. LaMarche (2003) 31 Cal.4th 728, 732, fn. 1.)

2 Sujan’s wife, Nita Patel, also sued alleging loss of consortium caused by defendants’ acts and omissions toward Sujan. The trial court concluded Patel’s cause of action did not appear to be covered by the anti-SLAPP statute. Because defendants do not specifically argue the order denying their motions should be reversed with respect to Patel’s cause of action, we need not address it separately in this appeal. (See Rosencrans v. Dover Images, Ltd. (2011) 192 Cal.App.4th 1072, 1089 [“Since there was no specific claim of error as to the loss of consortium cause of action, we do not reverse the trial court as to this cause of action.”].)

I.

FACTS AND PROCEDURAL BACKGROUND A. Sujan’s Complaint.

Sujan has been a board certified physician for over 20 years. He had admitting privileges at CRMC and practiced internal medicine there from August 2010 to July 2016. In an introductory paragraph to his complaint, Sujan claimed he was damaged by defendants’ “wrongful efforts to harm [his] practice.” Defendants’ alleged “scheme” included “the filing of false and defamatory internal complaints designed to destroy [Sujan’s] professional reputation” and “summarily suspending [his] admitting privileges under false pretenses.” Those acts were “intended to unfairly compete with [Sujan] and to convert [his] patients,” and they caused him “financial, mental, and emotional injury.”

Sujan alleged he provided his patients at CRMC “with a high degree of care and maintained strong professional relationships with his patients and many of his colleagues.” His “success [was] well documented” and, according to a data management system used by CRMC “to monitor physician performance,” the “mortality rate, readmission rate, and length-of-stay average” for his patients “were much lower than that of his peers.” Sujan achieved financial success at CRMC and signed “lucrative contracts” with insurance providers that expanded his practice and placed him in direct competition with Drs. Afifi, Yusufaly, and El-Bershawi, the individual defendants.

According to Sujan, the individual defendants responded to his competition and “growing practice” by “organiz[ing] certain members of the physician staff and registered nursing staff at CRMC” to engage in a “concerted and ongoing” campaign to defame

Sujan’s reputation through CRMC’s peer review process “by falsely depicting him as unresponsive, dilatory, and ill-tempered,” with the ultimate goal of having Sujan censured and/or suspended. CRMC abetted and/or conspired with the individual defendants in their campaign to defame Sujan, and it was financially motivated to so because it had an economic interest in recruiting and hiring physicians from EmCare (a healthcare recruiting and staffing company) and ousting physicians like Sujan, who were unaffiliated with EmCare.

Sujan alleged the individual defendants organized members of the physician and nursing staff to file dozens of “MIDAS reports” claiming Sujan “failed to adequately respond to pages and calls he received from the nursing staff.” A MIDAS report is a report from a staff member about an alleged violation of CRMC’s bylaws and/or state or federal law by a physician. If the director of risk management concludes the report meets CRMC’s peer review criteria, it is submitted to the relevant departmental quality review committee (QRC) to determine whether the bylaws or law(s) has been violated and, if so, it is forwarded to CRMC’s medical executive committee (MEC) to conduct a peer review and determine whether to restrict, supervise, or revoke the physician’s privileges.

According to Sujan, the allegations in the 86 MIDAS reports filed against him were “virtually all fabricated,” and “[n]early all of [them] failed to meet the hospital’s criteria for review.” While auditing the reports, the director of risk management learned of the scheme to defame Sujan and was shocked Sujan was being targeted. Most, if not all, of the reports alleged Sujan did not return calls or pages, but he showed his phone to the director to prove that “on several occasions” he did return calls or pages or he was

never called or paged to begin with. And while investigating the matter, the director spoke to nurse managers and was told that “some of the nurses at CRMC were being directed to submit MIDAS reports against [Sujan] based on false and/or misleading allegations.”3 In June 2016, a patient died of heart failure while under Sujan’s care. The patient suffered from various ailments, including a potentially deadly heart condition, and he was a heavy drug user. At the time, Dr. Afifi was chief of staff for the MEC. When Dr. Afifi learned of the death, he convened the MEC and summarily revoked Sujan’s admitting privileges “based on its conclusory finding [that] the suspension was necessary to avoid an imminent risk to patients.” According to Sujan, Dr. Afifi conducted no investigation to determine whether Sujan committed any wrongdoing, and he declined to conduct an analysis to determine the “root cause” of the patient’s death or to interview key witnesses such as Sujan or the head of the intensive care unit (ICU) at the time.

Some of Sujan’s colleagues who were familiar with his practice, including the “head of the ICU,” were shocked to learn of the summary suspension and wrote letters on his behalf. The patient’s insurance provider investigated the death and found no evidence of wrongdoing by Sujan, but no other investigation was conducted. According to Sujan, defendants had no interest in investigating the cause of the patient’s death or in determining whether Sujan had committed any wrongdoing. And, once Sujan’s

3 Sujan does not expressly allege the director of risk management found none of the MIDAS reports met the criteria for peer review and declined to forward any of them to the relevant QRC, but that is clearly the implication.

Free access — add to your briefcase to read the full text and ask questions with AI

Sujan v. Corona Regional Medical Center CA4/2, (Cal. Ct. App. 2021).

Sujan v. Corona Regional Medical Center CA4/2 (Sujan v. Corona Regional Medical Center CA4/2) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

El-Attar v. Hollywood Presbyterian Medical Center
301 P.3d 1146 (California Supreme Court, 2013)
Westlake Community Hospital v. Superior Court
551 P.2d 410 (California Supreme Court, 1976)
Applied Equipment Corp. v. Litton Saudi Arabia Ltd.
869 P.2d 454 (California Supreme Court, 1994)
Pacific Gas & Electric Co. v. Bear Stearns & Co.
791 P.2d 587 (California Supreme Court, 1990)
Nally v. Grace Community Church
763 P.2d 948 (California Supreme Court, 1988)
ELSENBERG v. Alameda Newspapers, Inc.
88 Cal. Rptr. 2d 802 (California Court of Appeal, 1999)
Freeman v. Schack
64 Cal. Rptr. 3d 867 (California Court of Appeal, 2007)
Navellier v. Sletten
52 P.3d 703 (California Supreme Court, 2002)
Rubin v. Green
847 P.2d 1044 (California Supreme Court, 1993)
Hassan v. Mercy American River Hospital
74 P.3d 726 (California Supreme Court, 2003)
Jarrow Formulas, Inc. v. LaMarche
74 P.3d 737 (California Supreme Court, 2003)
Korea Supply Co. v. Lockheed Martin Corp.
63 P.3d 937 (California Supreme Court, 2003)
Kibler v. Northern Inyo County Local Hospital District
138 P.3d 193 (California Supreme Court, 2006)
Taus v. Loftus
151 P.3d 1185 (California Supreme Court, 2007)
Lee v. Hanley
354 P.3d 334 (California Supreme Court, 2015)
Park v. Bd. of Trs. of the Cal. State Univ.
393 P.3d 905 (California Supreme Court, 2017)
Rand Resources, LLC v. City of Carson
433 P.3d 899 (California Supreme Court, 2019)
Wilson v. Cable News Network, Inc.
444 P.3d 706 (California Supreme Court, 2019)
Auto Equity Sales, Inc. v. Superior Court
369 P.2d 937 (California Supreme Court, 1962)
Action Apartment Ass'n v. City of Santa Monica
163 P.3d 89 (California Supreme Court, 2007)